Ji Wang et al. demonstrated that targeting the NUT family member 2A antisense RNA 1/miR-376a/Tet-eleven translocation 1/PD-L1 (NUTM2A-AS1/miR-376a/TET1/PD-L1) axis may provide a new strategy for GC diagnosis and treatment (Wang et al., 2020a). Here, TET1 is linked to gastric cancer.